Generic Drugs

Domestic and overseas generic drug companies

I   Real Status of Generic Drugs Market in Japan

• New goal has been set for the ratio of generic drugs used should be 80% in volume by 2020.
• The goal to occupy 80% of the entire volume of drugs used can be achieved soon, but the market of generic drugs is still vague.
• Promotions have been underway for generic drugs to be used 80% of the entire volume of drugs.

II    Strategies and Outlook of Generic Drugs in Pharmaceutical Companies

• Although the new goal has been set to 80% of the entire volume of drugs used, the market of generic drugs is still vague.
• The growth of generic drug makers has been slowing down.
• Foreign-affiliated pharmaceutical companies have been facing difficulties in the unique Japanese drugs market.
• As the growth of the generic drugs market having slowed down, new attempts are needed to invigorate the business.
• Since the demand of generic drugs is regarded to increase, the expenses for R&D and for facilities are on the rise.
• Distribution strategies by the generic drug companies:
• As generic drugs being accepted by more consumers, the number of MR has been flat or slightly declined.
• Evolving alliance strategies by generic drug makers:
• Authorized generic drugs have been increasing the existence in the generic drug market.
• Some differentiation strategies by generic drug makers.
• Biosimilar business has been invigorated.
• The sluggish growth of the domestic market has led some companies to enhance overseas business.
• Whether wider acceptance of a formulary be the key to expand the generic drug market.

III   Company Profiles